Tourmaline Bio Inc. (TRML)
undefined
undefined%
At close: undefined
21.81
-0.37%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - - - - -
Cost of Revenue 33.00K 6.00K 623.00K 447.00K 379.00K
Gross Profit -33.00K -6.00K -623.00K -447.00K -379.00K
Operating Income -45.41M -19.70M -904 -22.68M -18.38M
Interest Income - - - - 223.00K
Pretax Income -42.12M -19.70M -904 -22.71M -18.16M
Net Income -42.12M -19.70M -904 -22.71M -18.16M
Selling & General & Admin 13.04M 2.17M 692.00 6.96M 4.63M
Research & Development 32.37M 17.53M 212.00 15.28M 13.37M
Other Expenses - - - - -
Operating Expenses 45.41M 19.70M 904.00 22.24M 18.00M
Interest Expense - - - 23.00K -
Selling & Marketing Expenses - - - - -
Cost & Expenses 45.41M 19.70M 904.00 22.68M 18.38M
Income Tax - - -47.21M - -
Shares Outstanding (Basic) 4.75M 20.34M 10.88M 668.51K 4.13M
Shares Outstanding (Diluted) 4.75M 20.34M 10.88M 668.51K 4.13M
EPS (Basic) -8.87 -0.97 -0.00 -33.97 -4.39
EPS (Diluted) -8.87 -0.97 -0.00 -33.97 -4.39
EBITDA -45.38M -19.70M -46.88M -22.24M -17.78M
Depreciation & Amortization 33.00K 6.00K 904.00 447.00K 379.00K